161 related articles for article (PubMed ID: 23580587)
1. GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization.
Liu Q; Wang L; Wang Z; Yang Y; Tian J; Liu G; Guan D; Cao X; Zhang Y; Hao A
Carcinogenesis; 2013 Aug; 34(8):1728-36. PubMed ID: 23580587
[TBL] [Abstract][Full Text] [Related]
2. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
Zhang J; Chu D; Kawamura T; Tanaka K; He S
J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
[TBL] [Abstract][Full Text] [Related]
3. GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.
Yue X; Zhao P; Wu K; Huang J; Zhang W; Wu Y; Liang X; He X
Tumour Biol; 2016 Jul; 37(7):9789-96. PubMed ID: 26810068
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
6. Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.
Kumar P; Gullberg U; Olsson I; Ajore R
PLoS One; 2015; 10(5):e0123725. PubMed ID: 25974097
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.
Zhang XY; Li M; Sun K; Chen XJ; Meng J; Wu L; Zhang P; Tong X; Jiang WW
Oncotarget; 2015 Jan; 6(1):101-15. PubMed ID: 25575809
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells.
Zhang W; Du Y; Jiang T; Geng W; Yuan J; Zhang D
Mol Med Rep; 2015 Aug; 12(2):2919-25. PubMed ID: 25955394
[TBL] [Abstract][Full Text] [Related]
10. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo.
Wang T; Yan XB; Zhao JJ; Ye J; Jiang ZF; Wu DR; Xiao WH; Liu RY
Lung Cancer; 2011 Jun; 72(3):287-93. PubMed ID: 21040996
[TBL] [Abstract][Full Text] [Related]
11. GRIM-19 in Health and Disease.
Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
Zhou Y; Li M; Wei Y; Feng D; Peng C; Weng H; Ma Y; Bao L; Nallar S; Kalakonda S; Xiao W; Kalvakolanu DV; Ling B
J Interferon Cytokine Res; 2009 Oct; 29(10):695-703. PubMed ID: 19642906
[TBL] [Abstract][Full Text] [Related]
13. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
14. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.
Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV
Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633
[TBL] [Abstract][Full Text] [Related]
15. STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.
Jung JE; Kim HS; Lee CS; Shin YJ; Kim YN; Kang GH; Kim TY; Juhnn YS; Kim SJ; Park JW; Ye SK; Chung MH
Exp Mol Med; 2008 Oct; 40(5):479-85. PubMed ID: 18985005
[TBL] [Abstract][Full Text] [Related]
16. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
[TBL] [Abstract][Full Text] [Related]
17. The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma.
Cui L; Meng Q; Wen J; Yan Z; Gao Z; Tian Y; Xu P; Lian P; Yu H
J Biochem; 2018 Oct; 164(4):285-294. PubMed ID: 29961871
[TBL] [Abstract][Full Text] [Related]
18. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.
Chen K; Chen S; Huang C; Cheng H; Zhou R
Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829
[TBL] [Abstract][Full Text] [Related]
19. GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.
Nallar SC; Kalvakolanu DV
Cytokine Growth Factor Rev; 2017 Feb; 33():1-18. PubMed ID: 27659873
[TBL] [Abstract][Full Text] [Related]
20. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.
Kong D; Chen J; Sun X; Lin Y; Du Y; Huang D; Cheng H; He P; Yang L; Wu S; Zhao L; Meng X
Biosci Trends; 2019; 13(4):342-350. PubMed ID: 31527330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
